Gapping down
In reaction to earnings/guidance:
- CFMS -4.7% (lowered product revs outlook for Q3), KAR -3.1% (withdrew FY21 guidance and provided long-term targets), LEN -2.3%
Other news:
- VRCA -25.9% (received Complete Response Letter from FDA pertaining to VP-102 NDA for the treatment of molluscum contagiosum)
- STOK -4.9% (announced "positive" safety, pharmacokinetic and cerebrospinal fluid exposure data from Phase 1/2a MONARCH study of STK-001 in children and adolescents with Dravet syndrome)
- BILL -4.5% (proposes offering of $1.0 bln in shares of its common stock)
- VXX -2.8% (trading lower with US futures trading higher)
- ROLL -2.7% (announced offerings of common and mandatory convertible preferred stock)
- SLGN -0.9% (to acquire Gateway Plastics for $485 mln; expected to be slightly accretive to earnings in 2021)
Analyst comments:
- BIG -1.7% (downgraded to Neutral from Overweight at Piper Sandler)